FDA Adverse Event Malfunction Summary report: N

PRISM HCV

MDR report key: 9521760 · Received December 26, 2019

Report

Report Number
1415939-2019-00236
Event Type
Malfunction
Date Received
December 26, 2019
Report Date
February 24, 2020
Manufacturer
ABBOTT LABORATORIES
Product Code
QHM
UDI-DI
00380740062996
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

AN ERROR WAS IDENTIFIED ON FEBRUARY 13, 2020. THE INCORRECT PRODUCT CODE OF MZO (SECTION D.2B) WAS USED IN THE PREVIOUS SUBMISSIONS. THE CORRECT CODE IS QHM, THIS REPORT IS BEING SUBMITTED TO CORRECT THE PRODUCT CODE. THIS IS STILL A DUPLICATE SUBMISSION AND THE FOLLOW UP AND EVALUATION INFORMATION WAS PROVIDED IN THE FOLLOWING RELATED REPORTS: LOT 06088M700 IS DOCUMENTED IN MANUFACTURERS REPORT 1415939-2020-00004 LOT 04127M700 IS DOCUMENTED IN MANUFACTURERS REPORT 1415939-2020-00005 LOT 05046M700 IS DOCUMENTED IN MANUFACTURERS REPORT 1415939-2020-00006.

Additional Manufacturer Narrative · 0

THIS IS A DUPLICATE SUBMISSION AND IS NO LONGER NEEDED. THE FOLLOW UP AND EVALUATION INFORMATION WILL BE PROVIDED IN THE FOLLOWING RELATED REPORTS: LOT 06088M700 IS DOCUMENTED IN MANUFACTURERS REPORT 1415939-2020-00004 LOT 04127M700 IS DOCUMENTED IN MANUFACTURERS REPORT 1415939-2020-00005 LOT 05046M700 IS DOCUMENTED IN MANUFACTURERS REPORT 1415939-2020-00006.

Additional Manufacturer Narrative · 0

D4) ON 07JAN2020 THE SUSPECT MEDICAL DEVICE LOT NUMBER WAS PROVIDED AND UPDATED FROM UNKNOWN TO 04127M700. THE PRODUCT EVALUATION IS STILL IN PROCESS. A FOLLOW UP REPORT WILL BE PROVIDED WHEN THE EVALUATION IS COMPLETE.

Additional Manufacturer Narrative · 1

ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. AN EVALUATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED FALSE POSITIVE ANTI-HCV RESULTS ON THE PRISM ANALYZER. THE FOLLOWING DATA WAS PROVIDED: SID (B)(6) INITIAL 1.47, REPEAT 1.27, 1.25 S/CO, SID (B)(6) INITIAL 1.28, REPEAT 1.41, 1.42 S/CO, SID (B)(6) INITIAL 1.74, REPEAT 1.45, 1.57 S/CO. THE SAMPLES WERE NAT NEGATIVE. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1314214 PRISM HCV ANTI-HCV QHM ABBOTT LABORATORIES 04127M700 00380740062996

Patients

Seq Age Sex Outcome Treatment
1 LN 06A36-04 SN (B)(6)| LN 06A36-04 SN (B)(6)| LN 06A36-04 SN (B)(6)| LN 06A36-04 SN (B)(6)| PRISM ANALYZER| PRISM ANALYZER| PRISM ANALYZER| PRSIM ANALYZER